BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16322327)

  • 1. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
    Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
    Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas.
    Finelli P; Pierantoni GM; Giardino D; Losa M; Rodeschini O; Fedele M; Valtorta E; Mortini P; Croce CM; Larizza L; Fusco A
    Cancer Res; 2002 Apr; 62(8):2398-405. PubMed ID: 11956103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
    Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
    Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
    Queimado L; Lopes CS; Reis AM
    Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.
    Quade BJ; Weremowicz S; Neskey DM; Vanni R; Ladd C; Dal Cin P; Morton CC
    Cancer Res; 2003 Mar; 63(6):1351-8. PubMed ID: 12649198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA2: A pituitary tumour subtype-specific oncogene?
    Fedele M; Palmieri D; Fusco A
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.
    De Martino I; Visone R; Palmieri D; Cappabianca P; Chieffi P; Forzati F; Barbieri A; Kruhoffer M; Lombardi G; Fusco A; Fedele M
    Endocr Relat Cancer; 2007 Sep; 14(3):875-86. PubMed ID: 17914116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.
    Klemke M; Meyer A; Nezhad MH; Bartnitzke S; Drieschner N; Frantzen C; Schmidt EH; Belge G; Bullerdiek J
    Genes Chromosomes Cancer; 2009 Feb; 48(2):171-8. PubMed ID: 18980243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia.
    Pierantoni GM; Santulli B; Caliendo I; Pentimalli F; Chiappetta G; Zanesi N; Santoro M; Bulrich F; Fusco A
    Int J Oncol; 2003 Aug; 23(2):363-7. PubMed ID: 12851685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.
    Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A
    Cancer Cell; 2006 Jun; 9(6):459-71. PubMed ID: 16766265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies.
    Gross KL; Neskey DM; Manchanda N; Weremowicz S; Kleinman MS; Nowak RA; Ligon AH; Rogalla P; Drechsler K; Bullerdiek J; Morton CC
    Genes Chromosomes Cancer; 2003 Sep; 38(1):68-79. PubMed ID: 12874787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic mice.
    Lin HH; Xiong Y; Ho YS; Zhou B; Nguyen HV; Deng H; Lee R; Yen Y; Borok Z; Ann DK
    Eur J Oral Sci; 2007 Feb; 115(1):30-9. PubMed ID: 17305714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12-regulated miR-370-3p functions as a tumor suppressor gene by targeting HMGA2 in nonfunctional pituitary adenomas.
    Cai F; Dai C; Chen S; Wu Q; Liu X; Hong Y; Wang Z; Li L; Yan W; Wang R; Zhang J
    Mol Cell Endocrinol; 2019 May; 488():25-35. PubMed ID: 30853598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA2 overexpression in polycythemia vera with t(12;21)(q14;q22).
    Aliano S; Cirmena G; Garuti A; Fugazza G; Bruzzone R; Rocco I; Malacarne M; Ballestrero A; Sessarego M
    Cancer Genet Cytogenet; 2007 Sep; 177(2):115-9. PubMed ID: 17854665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
    Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
    Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
    Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas.
    Dahlén A; Mertens F; Rydholm A; Brosjö O; Wejde J; Mandahl N; Panagopoulos I
    Mod Pathol; 2003 Nov; 16(11):1132-40. PubMed ID: 14614053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas.
    Barbieri F; Bajetto A; Stumm R; Pattarozzi A; Porcile C; Zona G; Dorcaratto A; Ravetti JL; Minuto F; Spaziante R; Schettini G; Ferone D; Florio T
    Clin Cancer Res; 2008 Aug; 14(16):5022-32. PubMed ID: 18698020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel HMGA2 fusion sequences in lipoma: evidence that deletion of let-7 miRNA consensus binding site 1 in the HMGA2 3' UTR is not critical for HMGA2 transcriptional upregulation.
    Wang X; Hulshizer RL; Erickson-Johnson MR; Flynn HC; Jenkins RB; Lloyd RV; Oliveira AM
    Genes Chromosomes Cancer; 2009 Aug; 48(8):673-8. PubMed ID: 19431195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.